RankAlpha logo
Back to Rankings

ASTH

Astrana HealthA
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
View Chart
Current thesis
The post-earnings bull read is straightforward: Q1 showed 56% revenue growth, 82% adjusted EBITDA growth, strong free cash flow, reiterated guidance, and early evidence that full-risk contract conversions and Prospect integration are tracking acceptably [#8-K-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.3.
What can break
A large portion of the quarter's revenue growth came from the Prospect acquisition, so any integration miss or weaker-than-expected contribution could pressure the earnings-power narrative [#10-Q-2026-05-08].
Momentum
91
Value
59
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $36.00 · Bull $46.00 · Bear $28.00
Data freshness
Prices
As of 2026-07-21
Fundamentals
As of 2026-07-21 • Vendor: Data Vendor v1
Scores
As of 2026-07-21 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-21
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $49.33
Why
Momentum91 · Δ7d -3.3
Value59 · Δ7d +0.6
Sentiment43 · Δ7d +3.6
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
91
26% active weight
Current posture
7d trendSoftening
Δ7d
-3.3
Δ21d
+4.3
Value
59
39% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
+0.8
Sentiment
43
34% active weight
Current posture
7d trendImproving
Δ7d
+3.6
Δ21d
-2.4
Why this grade

Composite grade A. Momentum 90.9 / Value 58.5 / Sentiment 42.6

Fundamentals (TTM)
As of 2026-07-21
Market Cap
$2.25B
Beta
0.91
Shares Out
49.58M
P/E (TTM)
144.5
P/S (TTM)
0.47
P/FCF (TTM)
15.49
Rev YoY
+55.6%
EPS YoY
+114.8%
Gross Margin
+9.1%
Op Margin
+2.1%
Net Debt
$648.54M
Current Ratio
1.35
As of 2026-07-21 • Updated nightlySource: Internal modelMethodology